Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 317-326

  Lin, Huixian ^a,c   Xiao, Jiening ^a,c   Luo, Xiaobin ^a,b   Chen, Guorong ^a,b   Wang, Zhiguo ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c GUANGZHOU UNIVERSITY   (China)

Author keywords

HCN2; HCN4; Hypertrophy; Sp1; Transcription

Indexed keywords

ANGIOTENSIN II; ION CHANNEL; PROTEIN HCN2; PROTEIN HCN4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; ION CURRENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS;

EID: 66749108118     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218178     Document Type: Article

References (34)

1. Baruscotti M, DiFrancesco D: Pacemaker channels. Ann NY Acad Sci 2004;1015:111-121.
2. Cohen IS, Robinson RB: Pacemaker current and automatic rhythms: toward a molecular understanding. Handb Exp Pharmacol 2006;171:41-71.
3. Qu J, Barbuti A, Protas L, Santoro B, Cohen IS, Robinson RB: HCN2 overexpression in newborn and adult ventricular myocytes: distinct effects on gating and excitability. Circ Res 2001;89:E8-E14.
4. Stilli D, Sgoifo A, Macchi E, Zaniboni M, De Iasio S, Cerbai E, Mugelli A, Lagrasta C, Olivetti G, Musso E: Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats. Am J Physiol 2001;280:H142-H150.
5. Fernandez-Velasco M, Goren N, Benito G, Blanco-Rivero J, Bosca L, Delgado C: Regional distribution of hyperpolarization-activated current If and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J Physiol 2003;553:395-405.
6. Cerbai E, Sartiani L, DePaoli P, Pino R, Maccherini M, Bizzarri F, DiCiolla F, Davoli G, Sani G, Mugelli A: The properties of the pacemaker current If in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 2001;3:441-448.
7. f , in ventricular myocytes isolated from hypertensive rats. J Physiol 1994;481:585-591.
8. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 1996;94:1674-1681.
9. f , in ventricular myocytes from human failing heart. Circulation 1997;95:568-571.
10. f in ventricular myocytes isolated from control and hypertrophied rat hearts. Pflugers Arch 2006;452:146-154.
11. Han W, Bao W, Wang Z, Nattel S: Comparison of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle. Circ Res 2002;91:790-797.
12. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ: Hyperpolarization activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998;97:55-65.
13. f ) in normal and failing human heart. J Mol Cell Cardiol 2008;45:289-299.
14. Sridhar A, Dech SJ, LacombeVA, Elton TS, McCune SA, Altschuld RA, Carnes CA: Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats. Am J Physiol 2006;291:H2192-H2198.
15. f occurrence and properties in neonatal rat ventricular myocytes. Cardiovasc Res 1999;42:416-423.
16. f current and spontaneous activity in mouse embryonic ventricular myocytes. Circ Res 2001;88:536-542.
17. + channel gene mediates cell-growth signals on activation of oncoproteins Sp1 and NF-κB and inactivation of tumor suppressor Nkx3.1. J Cell Physiol 2007;212:137-147.
18. Ks -encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 2007;212:358-367.
19. Luo X, Xiao J, Lin H, Lu Y, Yang B, Wang Z: Genomic structure, transcriptional control and tissue distribution of human ERG1 and KCNQ1 genes. Am J Physiol 2008;294:H1371-H1380.
20. Lebeche D, Kaprielian R, Hajjar R: Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 2006;40:725-735.
21. Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M: An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol 2006;41:265-274.
22. Kadonaga JT, Courey AJ, Ladika J, Tjian R: Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 1998;242:1566-1570.
23. Pugh BF, Tjian R: Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 1990;61:1187-1197.
24. Yang B, Lin H, Xiao J, Luo X, Li B, Lu Y, Wang H, Wang Z: The muscle-specific microRNA miR-1 causes cardiac arrhythmias by targeting GJA1 and KCNJ2 genes. Nat Med 2007;13:486-491.
25. Black AR, Black JD, Azizkhan-Clifford J: Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143-160.
26. de Virginy DR: Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review. Heart Fail Rev 2006;11:333-334.
27. Azakie A, Fineman JR, He Y: Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo. Am J Physiol 2006;291:H600-H611.
28. ChenY, Currie RW: Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflamm Res 2005;54:338-343.
29. Tjian R: Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart. Curr Hypertens Rep 2003;5:454-458.
30. Marin M, Karis A, Visser P, Grosveld F, Philipsen S: Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997;89:619-628.
31. Saffer JD, Jackson SP, Annarella MB: Developmental expression of Sp1 in the mouse. Mol Cell Biol 1991;11:2189-2199.
32. Zhao C, Meng A: Sp1-like transcription factors are regulators of embryonic development in vertebrates. Dev Growth Differ 2005;47:201-211.
33. Kuratomi S, Kuratomi A, Kuwahara K, Ishii TM, Nakao K, Saito Y, Takano M: NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes. Biochem Biophys Res Commun 2007;353:67-73.
34. Luo X, Lin H, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z: Downregulation of miRNA-1/miRNA-133 contributes to reexpression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 2008;283:20045-20052.